GenEdit, Inc. is biotechnology company focused on the development of novel, non-viral, nanoparticle-based delivery technologies...
Ayar Labs Secures $35 Million in Series B Funding and Adds New Strategic and Global Investors as Interest in Optical Interconnect Grows
